Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes ASfiledCriticalNovozymes AS
Application grantedgrantedCritical
Publication of ES2551029T3publicationCriticalpatent/ES2551029T3/es
Variante de una alfa-amilasa madre de tipo Termamyl, donde (a) la variante comprende una o varias de las siguientes sustituciones: E376K; S417T; A420Q o R; S356A; o Y358F y además K176R+I201F+ H205N utilizando la numeración en SEC ID nº: 4, donde la alfa-amilasa madre de tipo Termamyl tiene un grado de identidad para SEC ID nº: 4 de al menos 80%, y (b) la variante tiene actividad de alfa-amilasa y además las variantes tienen y una estabilidad aumentada a pH por debajo de 7.0, y/o a concentraciones de calcio por debajo de 1 mM a temperaturas en el rango de 95°C a 160°C relativamente a la alfa-amilasa madre de tipo Termamyl.
ES06110159.8T1998-11-161999-11-16Variantes de alfa-amilasa
Expired - LifetimeES2551029T3
(es)
Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos